Searched for
OBESITY TREATMENT INDIA
Kiran Mazumdar-Shaw warns against long-term GLP-1 use, urges caution over weight-loss drugs, says 'for those who are not diabetic or clinically obese...'- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug sales
- 'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugs
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...15 Jun, 2026, 11.08 AM IST
- India's weight-loss drug boom raises questions over healthcare prioritiesIndia's market for cheaper anti-obesity drugs has surged tenfold. While demand is high, especially among those with diabetes, concerns abou...12 Jun, 2026, 11.48 PM IST
- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...12 Jun, 2026, 12.37 AM IST
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...11 Jun, 2026, 10.31 AM IST
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...09 Jun, 2026, 05.30 AM IST
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...03 Jun, 2026, 02.36 PM IST
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...02 Jun, 2026, 03.30 PM IST
- Covid is now hitting young Indians in a shocking new way, doctors say people in their 30s are suddenly needing hip replacementsHip replacement surgeries among Indians in their 30s and 40s have reportedly risen by nearly 40 per cent in the post-Covid period. Doctors ...25 May, 2026, 05.30 PM IST
- Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weig...22 May, 2026, 05.08 PM IST
- No cosmetic job with jabs, warns drug regulator CDSCOThe notice issued by the Central Drugs Standard Control Organisation (CDSCO) cites provisions of the Drugs and Cosmetics Act, 1940, and the...21 May, 2026, 06.00 AM IST
- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...18 May, 2026, 06.40 PM IST
- Best ways to find the right health insurance policy: A comparison of ICICI Lombard, HDFC Ergo, Care, Niva Bupa, Tata AIG policiesChoosing a health insurance policy involves more than just premium cost. This comparison of leading Indian insurers highlights key features...15 May, 2026, 11.29 AM IST
- Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vialEli Lilly is making Alzheimer's a major focus for its future innovations. The company is also expanding its specialty medicine offerings in...14 May, 2026, 12.45 AM IST
- Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...13 May, 2026, 03.00 PM IST
- Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarityEli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...12 May, 2026, 06.57 AM IST
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- Dr Reddy's and Nestle Health Science strengthen presence in diabetes, obesity nutrition spaceDr Reddy's teams up with Nestle Health Science to introduce Celevida GLP+, a specialized supplement crafted for those navigating the challe...07 May, 2026, 07.03 PM IST
Load More
